Who
Richard Bryan Riggsbee
CFO
Company insider
Files Form 4 as: CFO, Neogen; Director, CareDx; Chief Financial Officer, Myriad Genetics.
In numbers
- Trades disclosed
- 84
- Buys
- 0
- Sells
- 8
- Bought
- $0
- Sold
- $3.4M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 17 Oct 2014
- Last trade
- 14 Aug 2026
- Last filed
- 14 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 14 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $600K51,502 at $11.65 | filing |
| 14 Aug 2026filed 14 Aug 2026 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —261,702 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —261,702 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $600K51,502 at $11.65 | filing |
| 12 Jun 2026filed 16 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —9,795 at $0.00 | filing |
| 12 Jun 2026filed 16 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —9,795 at $0.00 | filing |
| 3 Nov 2025filed 5 Nov 2025 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —459,713 at $0.00 | filing |
| 3 Nov 2025filed 5 Nov 2025 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $1.1M178,855 at $6.29 | filing |
| 13 Jun 2025filed 17 Jun 2025 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —12,103 at $0.00 | filing |
| 14 Jun 2024filed 20 Jun 2024 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,048 at $0.00 | filing |
| 14 Jun 2024filed 17 Jun 2024 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,048 at $0.00 | filing |
| 14 Jun 2024filed 17 Jun 2024 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —10,570 at $0.00 | filing |
| 13 Jun 2024filed 20 Jun 2024 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —9,760 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | CDNA CareDxoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —9,760 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code A | —6,844 at $0.00 | filing |
| 1 Dec 2023filed 5 Dec 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $573K30,000 at $19.09 | filing |
| 1 Nov 2023filed 3 Nov 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Sold | $471K30,000 at $15.69 | filing |
| 9 Oct 2023filed 10 Oct 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $74K4,954 at $15.01 | filing |
| 9 Oct 2023filed 10 Oct 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $111K7,382 at $15.01 | filing |
| 26 Sep 2023filed 27 Sep 2023 | MYGN Myriad GeneticsDiagnostics & Labs | SEC FORM 4 Code F | $72K4,517 at $15.99 | filing |
News
Financial Review: Myriad Genetics (NASDAQ:MYGN) & AnaptysBio (NASDAQ:ANAB)MYGN · tickerreport.com · 20 Oct 2026Molecular Diagnostic Stock Myriad Genetics (NASDAQ: MYGN) Gains on News of Selling Prenatal Health Testing BusinessMYGN · investorideas.com · 20 Oct 2026FinancialContent - Myriad Genetics (MYGN) Stock Trades Up, Here Is WhyMYGN · financialcontent.com · 20 Oct 2026
0 headlines in the last 90 days name Richard Bryan Riggsbee; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.